Technical information
Manufacturer
NOVARTIS PHARMA S.A.S
Presentation
MENOREST 25 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 350 134-6)
MENOREST 37,5 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 247-9)
MENOREST 50 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 239-6)
MENOREST 75 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 241-0)
MENOREST 100 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 243-3)
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
nFB4rcDszrVG1fud